“Obesity is a significant risk factor for breast cancer, and while it is very preliminary data, our studies in mice suggest that these new anti-obesity drugs may be a way to reduce obesity-associated breast cancer risk or improve outcomes,” said study author Amanda Kucinskas, B.S., a Ph.D. candidate in the labs of Drs. Erin Giles and Kanakadurga Singer at the University of Michigan in Ann Arbor, Mich.

Existing research has shown that having obesity can lead to worse breast cancer outcomes compared to those who do not have obesity, and weight loss can improve outcomes. However, there are many challenges with traditional weight loss methods.

Kucinskas and colleagues leveraged tirzepatide, one of a new class of effective anti-obesity medications that target GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. The researchers sought to learn whether or not tirzepatide would reduce obesity-associated breast cancer growth.

This mouse study included 16 mice. The 9-week-old C57BL/6 mice were fed a 40% high-fat diet and housed in a warm environment to induce obesity. At 32 weeks of age, the mice with obesity were randomly assigned injections of tirzepatide or a placebo every other day for 16 weeks. Tumor volumes were measured twice weekly.

The researchers found that the anti-obesity drug reduced body weight and body fat by approximately 20% in mice, similar to the amount of weight loss achieved by women on this drug. They found this was primarily due to a loss of adipose mass, with a reduction in adipose depot weights compared to controls.

The anti-obesity drug also reduced tumor volume compared to the controls. At the end of the study, the researchers found that tumor volume was significantly correlated with body weight, total adipose mass and the amount of fat stored in the liver.

“While these are very preliminary results, they suggest that this new anti-obesity drug may also have a beneficial impact on breast cancer outcomes,” Kucinskas said.

Ongoing studies are underway in collaboration with Dr. Steve Hursting’s lab at the University of North Carolina at Chapel Hill to separate the weight loss from the tumor-specific effects of tirzepatide.

Scientists from the University of South Australia (UniSA) have developed a long-acting injectable formulation that delivers a steady dose of levodopa and carbidopa – two key medications for Parkinson’s – over an entire week.

Their findings have been reported in the journal Drug Delivery and Translational Research.

The biodegradable formulation is injected under the skin or into muscle tissue, where it gradually releases the medication over seven days.

Parkinson’s disease is the second most common neurological disorder, affecting more than 8.5 million people worldwide. Currently there is no cure and the symptoms – tremors, rigidity and slow movement – are managed with oral medications that must be taken several times a day.

The frequent dosing is a burden, especially for elderly patients or those with swallowing difficulties, leading to inconsistent medication levels, more side effects, and reduced effectiveness.

Lead researcher Professor Sanjay Garg, from UniSA’s Centre for Pharmaceutical Innovation, says the newly developed injectable could significantly improve treatment outcomes and patient adherence.

“Our goal was to create a formulation that simplifies treatment, improves patient compliance, and maintains consistent therapeutic levels of medication. This weekly injection could be a game-changer for Parkinson’s care,” Prof Garg says.

“Levodopa is the gold-standard therapy for Parkinson’s, but its short life span means it must be taken several times a day.”

UniSA PhD student Deepa Nakmode says the in-situ implant is designed to release both levodopa and carbidopa steadily over one week, maintaining consistent plasma levels and reducing the risks associated with fluctuating drug concentrations.

“After years of focused research, it’s incredibly rewarding to see our innovation in long-acting injectables for Parkinson’s disease reach this stage. Our invention has now been filed for an Australian patent,” Nakmode says.

The injectable gel combines an FDA-approved biodegradable polymer PLGA with Eudragit L-100, a pH-sensitive polymer, to achieve a controlled and sustained drug release.

Extensive lab tests confirmed the system’s effectiveness and safety:

• More than 90% of the levodopa dose and more than 81% of the carbidopa dose was released over seven days.
• The implant degraded by over 80% within a week and showed no significant toxicity in cell viability tests.
• The formulation can be easily administered through a fine 22-gauge needle, minimising discomfort and eliminating the need for surgical implant.

“The implications of this research are profound,” Prof Garg says. “By reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson’s therapy. We’re not just improving how the drug is delivered; we’re improving patients’ lives.”

Prof Garg says the technology could also be adapted for other chronic conditions such as cancer, diabetes, neurodegenerative disorders, pain management, and chronic infections that require long-term drug delivery.

The system can be tuned to release drugs over a period ranging from a few days to several weeks depending on therapeutic needs.

UniSA scientists hope to start clinical trials in the near future and are exploring commercialisation opportunities.

Now, scientists at the Stowers Institute for Medical Research have identified how two distinct genes guide the regeneration of sensory cells in zebrafish. The discovery improves our understanding of how regeneration works in zebrafish and may guide future studies on hearing loss and regenerative medicine in mammals, including humans.

“Mammals such as ourselves cannot regenerate hair cells in the inner ear,” said Stowers Investigator Tatjana Piotrowski, Ph.D., the study’s co-author. “As we age or are subjected to prolonged noise exposure, we lose our hearing and balance.”

New research from the Piotrowski Lab, published in Nature Communications on July 14, 2025, seeks to understand how cell division is regulated to both promote regeneration of hair cells and to also maintain a steady supply of stem cells. Led by former Stowers Researcher Mark Lush, Ph.D., the team discovered that two different genes regulating cell division each control the growth of two key types of sensory support cells in zebrafish. The finding may help scientists study whether similar processes could be triggered in human cells in the future.

“During normal tissue maintenance and regeneration, cells need to proliferate to replace the cells that are dying or being shed — however, this only works if there are existing cells that can divide to replace them,” said Piotrowski. “To understand how proliferation is regulated, we need to understand how stem cells and their offspring know when to divide and at what point to differentiate.”

Zebrafish are an excellent system for studying regeneration. Dotted in a straight line from their head to tailfin are sensory organs called neuromasts. Each neuromast resembles a garlic bulb with “hair cells” sprouting from its top. A variety of supporting cells encompass the neuromast to give rise to new hair cells. These sensory cells, which help zebrafish detect water motion, closely resemble those in the human inner ear.

Because zebrafish are transparent during development and have accessible sensory organ systems, scientists can visualize, as well as genetically sequence and modify, each neuromast cell. This allows them to investigate the mechanisms of stem cell renewal, the proliferation of progenitor cells — direct precursors to hair cells — and hair cell regeneration.

“We can manipulate genes and test which ones are important for regeneration,” said Piotrowski. “By understanding how these cells regenerate in zebrafish, we hope to identify why similar regeneration does not occur in mammals and whether it might be possible to encourage this process in the future.”

Two key populations of support cells contribute to regeneration within neuromasts: active stem cells at the neuromast’s edge and progenitor cells near the center. These cells divide symmetrically, which allows the neuromast to continuously make new hair cells while not depleting its stem cells. The team used a sequencing technique to determine which genes were active in each type and found two distinct cyclinD genes present in only one or the other population.

The researchers then genetically altered each gene in the stem and progenitor populations. They discovered that the different cyclinD genes were independently regulating cell division of the two types of cells.

“When we rendered one of these genes non-functional, only one population stopped dividing,” said Piotrowski. “This finding shows that different groups of cells within an organ can be controlled separately, which may help scientists understand cell growth in other tissues, such as the intestine or blood.”

Progenitor cells lacking their cell type-specific cyclinD gene did not proliferate; however, they did form a hair cell, uncoupling cell division with differentiation. Notably, when the stem cell-specific cyclinD gene was engineered to work in progenitor cells, progenitor cell division was restored.

David Raible, Ph.D., a professor at the University of Washington who studies the zebrafish lateral line sensory system, commented on the significance of the new study. “This work illuminates an elegant mechanism for maintaining neuromast stem cells while promoting hair cell regeneration. It may help us investigate whether similar processes exist or could be activated in mammals.”

Because cyclinD genes also regulate proliferation in many human cells, like those in the gut and blood, the team’s findings may have implications beyond hair cell regeneration.

“Insights from zebrafish hair cell regeneration could eventually inform research on other organs and tissues, both those that naturally regenerate and those that do not,” said Piotrowski.

Additional authors include Ya-Yin Tsai, Shiyuan Chen, Daniela Münch, Julia Peloggia, Ph.D., and Jeremy Sandler, Ph.D.

This work was funded by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (NIH) (award: 1R01DC015488-01A1), the Hearing Health Foundation, and with institutional support from the Stowers Institute for Medical Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Earlier observations of this star, called MP Mus, suggested that it was all alone without any planets in orbit around it, surrounded by a featureless cloud of gas and dust.

However, a second look at MP Mus, using a combination of results from the Atacama Large Millimeter/submillimeter Array (ALMA) and the European Space Agency’s Gaia mission, suggest that the star is not alone after all.

The international team of astronomers, led by the University of Cambridge, detected a large gas giant in the star’s protoplanetary disc: the pancake-like cloud of gases, dust and ice where the process of planet formation begins. This is the first time that Gaia has detected an exoplanet within a protoplanetary disc. The results, reported in the journal Nature Astronomy, suggest that similar methods could be useful in the hunt for young planets around other stars.

By studying how planets form in the protoplanetary discs around young stars, researchers can learn more about how our own Solar System evolved. Through a process known as core accretion, gravity causes particles in the disc to stick to each other, eventually forming larger solid bodies like asteroids or planets. As young planets form, they start to carve gaps in the disc, like grooves on a vinyl record.

However, observing these young planets is extremely challenging, due to the interference from the gas and dust in the disc. To date, only three robust detections of young planets in a protoplanetary disc have been made.

Dr Álvaro Ribas from Cambridge’s Institute of Astronomy, who led the research, specialises in studying protoplanetary discs. “We first observed this star at the time when we learned that most discs have rings and gaps, and I was hoping to find features around MP Mus that could hint at the presence of a planet or planets,” he said.

Using ALMA, Ribas observed the protoplanetary disc around MP Mus (PDS 66) in 2023. The results showed a young star seemingly all alone in the universe. Its surrounding disc showed none of the gaps where planets might be forming, and was completely flat and featureless.

“Our earlier observations showed a boring, flat disc,” said Ribas. “But this seemed odd to us, since the disc is between seven and ten million years old. In a disc of that age, we would expect to see some evidence of planet formation.”

Now, Ribas and his colleagues from Germany, Chile, and France have given MP Mus another chance. Once again using ALMA, they observed the star at the 3mm range, a longer wavelength than the earlier observations, allowing them to probe deeper into the disc.

The new observations turned up a cavity close to the star and two gaps further out, which were obscured in the earlier observations, suggesting that MP Mus may not be alone after all.

At the same time, Miguel Vioque, a researcher at the European Southern Observatory, was uncovering another piece of the puzzle. Using data from Gaia, he found MP Mus was ‘wobbling’.

“My first reaction was that I must have made a mistake in my calculations, because MP Mus was known to have a featureless disc,” said Vioque. “I was revising my calculations when I saw Álvaro give a talk presenting preliminary results of a newly-discovered inner cavity in the disc, which meant the wobbling I was detecting was real and had a good chance of being caused by a forming planet.”

Using a combination of the Gaia and ALMA observations, along with some computer modelling, the researchers say the wobbling is likely caused by a gas giant – less than ten times the mass of Jupiter – orbiting the star at a distance between one and three times the distance of the Earth to the Sun.

“Our modelling work showed that if you put a giant planet inside the new-found cavity, you can also explain the Gaia signal,” said Ribas. “And using the longer ALMA wavelengths allowed us to see structures we couldn’t see before.”

This is the first time an exoplanet embedded in a protoplanetary disc has been indirectly discovered in this way – by combining precise star movement data from the Gaia with deep observations of the disc. It also means that many more hidden planets might exist in other discs, just waiting to be found.

“We think this might be one of the reasons why it’s hard to detect young planets in protoplanetary discs, because in this case, we needed the ALMA and Gaia data together,” said Ribas. “The longer ALMA wavelength is incredibly useful, but to observe at this wavelength requires more time on the telescope.”

Ribas says that upcoming upgrades to ALMA, as well as future telescopes such as the next generation Very Large Array (ngVLA), may be used to look deeper into more discs and better understand the hidden population of young planets, which could in turn help us learn how our own planet may have formed.

The research was supported in part by the European Union’s Horizon Programme, the European Research Council, and the UK Science and Technology Facilities Council (STFC), part of UK Research and Innovation (UKRI).

Particle Astrophysicists have proposed the existence of a strange new type of star-like object, called a ‘dark dwarf’, which may be quietly glowing in the center of our galaxy.

Far from being dark in appearance, these unusual objects are powered by dark matter (the invisible substance thought to make up about a quarter of the universe).

The discovery comes from a UK-US research team and the full research findings has been published in the Journal of Cosmology and Astroparticle Physics (JCAP).

Using theoretical models, the scientists suggest that dark matter can get trapped inside young stars, producing enough energy to stop them from cooling and turning them into stable, long-lasting objects they call dark dwarfs.

Dark dwarfs are thought to form from brown dwarfs, which are often described as failed stars.

Brown dwarfs are too small to sustain the nuclear fusion that powers most stars, so they cool and fade over time. But if they sit in a dense pocket of dark matter, like near the Milky Way’s center, they could capture dark matter particles.

If those particles then collide and destroy each other, they release energy keeping the dark dwarf glowing indefinitely.

The existence of these objects depends on dark matter being made of specific kinds of particles, known as WIMPs (Weakly Interacting Massive Particles).

These are heavy particles that barely interact with ordinary matter, but could annihilate with one another inside stars, providing the energy needed to keep a dark dwarf alive.

To tell dark dwarfs apart from other faint objects like brown dwarfs, the scientists point to a unique clue: lithium.

The researchers believe dark dwarfs would still contain a rare form of lithium called lithium-7.

In normal stars, lithium-7 gets burned up quickly. So, if they find an object that looks like a brown dwarf but still has lithium-7 that’s a strong hint it’s something different.

Study co-author Dr Djuna Croon of Durham University, said: “The discovery of dark dwarfs in the galactic center would give us a unique insight into the particle nature of dark matter.”

The team believes that telescopes like the James Webb Space Telescope could already be capable of spotting dark dwarfs, especially when focusing on the center of the galaxy.

Another approach might be to look at many similar objects and statistically determine whether some of them could be dark dwarfs.

Finding just one of these dark dwarfs, the researchers say, would be a major step towards uncovering the true nature of dark matter.

Findings from analyses of the Northwest Africa 16286 meteorite, presented at the Goldschmidt Conference in Prague, offer fresh insights into how the Moon’s interior evolved, highlighting the long-lived nature of its volcanic activity.

Analyses by researchers from the University of Manchester, UK, lend weight to a theory that the Moon retained internal heat-generating processes that powered lunar volcanic activity in several distinct phases.

Lead isotope analysis dates the rock’s formation to around 2.35 billion years ago, during a period from which few lunar samples exist, making it the youngest basaltic lunar meteorite discovered on Earth. Its rare geochemical profile sets it apart from those returned by previous Moon missions, with chemical evidence indicating it likely formed from a lava flow that solidified after emerging from deep within the Moon.

Dr Joshua Snape, a Research Fellow at the University of Manchester, UK, is presenting the research at the Goldschmidt Conference. He said: “Lunar rocks from sample return missions are fantastic in the insights they provide us, but they are limited to the immediate areas surrounding those mission landing sites. By contrast, lunar meteorites can potentially be ejected by impact cratering occurring anywhere on the Moon’s surface. As such, there’s some serendipity surrounding this sample; it just happened to fall to Earth and reveals secrets about lunar geology without the massive expense of a space mission.”

Containing relatively large crystals of mineral olivine, the rock is a type of lunar volcanic basalt called olivine-phyric basalt. It contains moderate levels of titanium, high levels of potassium. In addition to the unusual age of the sample, this study found that the Pb isotope composition of the rock – a geochemical fingerprint retained from when the rock formed – points to it originating from a source in the Moon’s interior with an unusually high uranium-to-lead ratio. These chemical clues may help identify the mechanisms that have enabled periods of ongoing internal heat generation on the Moon.

“The age of the sample is especially interesting because it fills an almost billion-year gap in lunar volcanic history,” said Dr Snape. “It’s younger than the basalts collected by the Apollo, Luna and Chang’e 6 missions, but older than the much younger rocks brought back by China’s Chang’e 5 mission. Its age and composition show that volcanic activity continued on the Moon throughout this timespan, and our analysis suggests an ongoing heat generation process within the Moon, potentially from radiogenic elements decaying and producing heat over a long period.

“Moon rocks are rare, so it’s always interesting when we get something that stands out and looks different to everything else. This particular rock provides new constraints about when and how volcanic activity occurred on the Moon. There is much more yet to learn about the Moon’s geological past, and with further analysis to pinpoint its origin on the surface, this rock will guide where to land future sample return missions.”

The 311-gram meteorite is only one of 31 lunar basalts officially identified on Earth. Its distinct composition, with melted glassy pockets and veins, suggests it was likely shocked by an asteroid or meteorite impact on the Moon’s surface before being ejected and eventually falling to Earth. This shock event makes it more challenging to interpret the date obtained for the rock, but the researchers estimate its age with a margin of plus or minus 80 million years.

The research was funded by the Royal Society, and the researchers plan to publish their findings in full in a peer-reviewed journal later this year.